Global/International

QuidelOrtho and BÜHLMANN Launch FCAL® Turbo and FPELA® Turbo Assays on VITROS™ Systems

New MicroTip™ Partnership Assays Enhance Automated Gastrointestinal Testing Capabilities on VITROS™ Platforms...

HistoSonics Secures Expanded Insurance Coverage for Liver Tumor Therapy

Non-Invasive Histotripsy Treatment Now Accessible to 7 Million Blue Cross Blue Shield Highmark Members Across U.S....

Zimmer Biomet to Acquire Monogram Technologies in Strategic Move to Enhance Robotic Surgery Portfolio

Definitive agreement strengthens Zimmer Biomet’s position in orthopedic innovation by integrating autonomous robotic technology into its surgical solutions suite....

Medtronic Responds to CMS Proposed National Coverage Determination for Symplicity Spyral™ RDN System

Company Welcomes Milestone Toward Expanding Medicare Access to Innovative Renal Denervation Therapy for Uncontrolled Hypertension...

FDA Lists 90+ AR/VR Medical Devices Approved Between 2015–2025, Cementing a Decade of Immersive Tech in Clinical Care

With dozens of approved devices across neurology, orthopaedics, and radiology, the FDA underscores its commitment to guiding safe, innovative integration of augmented and virtual reality in healthcare...

The 2025 Index: 100 FDA-Approved AI-Driven Medical Devices

Spanning Radiology, Cardiology, Neurology, and More, the List Highlights FDA’s Ongoing Commitment to Advancing Safe and Effective AI Integration in Healthcare...

Dräger Honored with 2025 Global Company of the Year Award by Frost & Sullivan

Recognition Highlights Dräger’s Leadership and Innovation in Advancing Respiratory Device Technologies Worldwide...

SS Innovations Completes World’s First Robotic Telesurgery for Bariatric Procedure Using SSi Mantra 3

Groundbreaking remotely performed weight-loss surgery marks a global milestone in surgical robotics and telemedicine innovation...

SimBioSys Earns Third FDA Clearance for TumorSight™ Viz

AI-Powered 3D Surgical Planning Tool Advances Precision Breast Cancer Surgery with Latest Regulatory Milestone...

U.S. FDA Grants Breakthrough Device Designation to Artera’s AI-Powered Prostate Cancer Decision Support Tool

Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients....